{"schema_version":"alpha-profile-public-v1","slug":"peter-blume-jensen-m-d-ph-d","canonical_url":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d","as_of":"2026-09-22T00:16:42.62364+00:00","published_at":"2026-09-02T02:37:22.388172+00:00","last_reviewed_at":"2026-05-15T21:42:18.905+00:00","identity":{"display_name":"Peter Blume-Jensen, M.D., Ph.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Acrivon Therapeutics, Inc.","company_slug":"acrivon-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2018-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-24T20:10:02.508+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=peter-blume-jensen-m-d-ph-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=peter-blume-jensen-m-d-ph-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Blume-Jensen is the main founder and has served as CEO, acting Chief Scientific Officer, and President since March 2018, and Chairman since October 2020. He has extensive experience in oncology research and development and oncogenic kinase signaling, with numerous highly cited publications. He previously held leadership positions at XTuit Pharmaceuticals, Metamark Genetics, Daiichi Sankyo, Merck & Co., and Serono."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Acrivon Therapeutics, Inc.","organizationId":"acrivon-therapeutics-inc","title":"Director","period":"2018-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Acrivon Therapeutics, Inc.","company_slug":"acrivon-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2018-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-24T20:10:02.508+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Peter Blume-Jensen, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:19.104582+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:19.001633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Chair","claim_text":"Peter Blume-Jensen, M.D., Ph.D. currently serves as Chair at Acrivon Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:19.070402+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:19.001633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Peter Blume-Jensen, M.D., Ph.D. serves on no disclosed committees.","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:19.088523+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:19.001633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Acrivon Therapeutics, Inc.","claim_text":"Peter Blume-Jensen, M.D., Ph.D. is linked to Acrivon Therapeutics, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:19.203115+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:19.001633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer, President and Chairman","claim_text":"Peter Blume-Jensen, M.D., Ph.D. is also listed as Chief Executive Officer, President and Chairman.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:19.184848+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:19.001633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Peter Blume-Jensen, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:19.136212+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:19.001633+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Peter Blume-Jensen, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:19.120769+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:19.001633+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:peter-blume-jensen-m-d-ph-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2018-01-01 · current","organization":"Acrivon Therapeutics, Inc.","organization_id":"acrivon-therapeutics-inc"},"claim_text":"Director at Acrivon Therapeutics, Inc. (2018-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d#profile","url":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d","dateModified":"2026-05-15T21:42:18.905+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d#person","name":"Peter Blume-Jensen, M.D., Ph.D.","url":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Acrivon Therapeutics, Inc.","tickerSymbol":"NASDAQ: ACRV"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2018-01-01","memberOf":{"@type":"Organization","name":"Acrivon Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/acrivon-therapeutics-inc","tickerSymbol":"NASDAQ: ACRV"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","name":"ACRV DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-15T21:42:18.905+00:00","observed_at":"2026-09-22T00:16:42.62364+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"peter-blume-jensen-m-d-ph-d","canonical_url":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d"},"publication":{"published_at":"2026-09-02T02:37:22.388172+00:00","last_reviewed_at":"2026-05-15T21:42:18.905+00:00","as_of":"2026-09-22T00:16:42.62364+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/peter-blume-jensen-m-d-ph-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/peter-blume-jensen-m-d-ph-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}